Anne Bang profile page

Patient-specific primary cells and human induced pluripotent stem cells (hiPSC) complement traditional cell-based drug discovery assays and could aid in the development of clinically useful compounds. We will discuss our high content screening results and development of patient specific hiPSC based models for drug discovery.